Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Total Debt: 2011-2024

Historic Total Debt for Mimedx Group (MDXG) over the last 8 years, with Dec 2024 value amounting to $18.8 million.

  • Mimedx Group's Total Debt fell 12.76% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year decrease of 12.76%. This contributed to the annual value of $18.8 million for FY2024, which is 61.65% down from last year.
  • Latest data reveals that Mimedx Group reported Total Debt of $18.8 million as of FY2024, which was down 61.65% from $49.1 million recorded in FY2023.
  • In the past 5 years, Mimedx Group's Total Debt registered a high of $49.1 million during FY2023, and its lowest value of $18.8 million during FY2024.
  • Its 3-year average for Total Debt is $38.8 million, with a median of $48.6 million in 2022.
  • In the last 5 years, Mimedx Group's Total Debt increased by 1.04% in 2023 and then tumbled by 61.65% in 2024.
  • Mimedx Group's Total Debt (Yearly) stood at $47.7 million in 2020, then rose by 0.90% to $48.1 million in 2021, then increased by 0.97% to $48.6 million in 2022, then increased by 1.04% to $49.1 million in 2023, then slumped by 61.65% to $18.8 million in 2024.